Compare Johnson & Johnson (JNJ) vs Microsoft (MSFT) Price & Performance

Johnson & JohnsonTrade

MicrosoftTrade

Price performance (Past 24H)

Key statistics

Johnson & Johnson vs Microsoft — how do they compare? Johnson & Johnson trades at $251.13 (market cap $598.96B), while Microsoft trades at $397.69 (market cap $2.99T). The key difference: Microsoft is far larger — about 5× Johnson & Johnson's market cap, and Johnson & Johnson pays the higher dividend (2.15%). Which is the better fit depends on your goals.

	JNJ	MSFT
Market Cap	$598.96B	$2.99T
Volume	6,156,228	36,654,621
Sector	Health	Technology
52-Week High	$267.24	$542.07
52-Week Low	$164.36	$352.83
Enterprise Value	$631.90B	$2.97T
Dividend Yield	2.15%	0.9%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Johnson & Johnson

No Aura AI signal available yet.

Microsoft

Microsoft (MSFT) trades at $397.74, up 1.0% today, with a bullish technical signal and strong fundamentals. The stock shows consistent earnings beats, with Q1 2026 EPS of $4.27 exceeding the $4.06 estimate. Revenue grew to $281.72B in 2025, with a net income margin of 39.34%. Analyst sentiment is overwhelmingly positive, with 80.49% buy ratings and a consensus price target of $546.70. Recent news highlights AI leadership and Azure momentum, though concerns over capital expenditures persist.

The outlook for MSFT remains favorable, driven by AI integration and cloud growth, but risks include competitive pressures and macroeconomic volatility. With a P/E of 23.96, the valuation is reasonable given robust profitability. Institutional confidence is high, supporting potential upside toward the $546.70 target, though investors should monitor execution on AI investments and market sentiment shifts.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

JNJ

Head and neck squamous cell carcinoma market to grow at 10.5% CAGR by 2036 driven by new immunotherapiesNa · 3 hours agoBullish 2025 tax law boosts US manufacturing jobs, wages, and growth across all 50 statesFox Business · 12 hours agoBullish DIVO ETF up 6.6% YTD but faces pressure from high Treasury yields and low volatility.24/7 Wall Street · 4 days agoNeutral View details →

MSFT

Roundhill Magnificent Seven ETF offers equal exposure to top 7 mega-cap tech stocks but with higher risk and cost.24/7 Wall Street · 4 hours agoNeutral Microsoft shifts to AI-driven revenue model amid record $190B capex and strong demand.Seeking Alpha · 5 hours agoBullish OpenAI and Anthropic boost lobbying to $3.17M in Q2 ahead of IPOs and midtermsCNBC · 7 hours agoNeutral View details →

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

About Microsoft

Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.